Clinical Trials Browser

Phase EARLY_PHASE1 × Breast Neoplasms × ruxolitinib × Clear all

NCT06008275 2025-11-10

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms